In 2023, the share of Brazil's scientific publications among the world's 10% top-cited in Endocrinology, Diabetes, and Metabolism stood notably high, laying a strong foundation for future growth. From 2024 to 2028, there is a projected steady annual increase, with year-on-year variations showing consistent improvement. The compound annual growth rate (CAGR) over these five years suggests a healthy upward trend, indicative of Brazil's strengthening presence in this scientific domain.
Future trends to watch for:
- Potential shifts in funding and research priorities within Brazil affecting publication rates.
- Collaborations with international research bodies could further bolster citation impact.
- Technological advancements and innovations in research methodologies may enhance scientific outputs.